IN BRIEF: Polarean Imaging gets FDA approval for MRI chest coil

Polarean Imaging PLC - medical imaging technology developer - Receives 510k clearance from the US ...

Alliance News 21 November, 2024 | 6:28PM
Email Form Facebook Twitter LinkedIn RSS

Polarean Imaging PLC - medical imaging technology developer - Receives 510k clearance from the US Food & Drug Administration for its specialised MRI chest coil to now include GE Healthcare Technologies Inc's 3 Tesla, or 3T, MRI scanners, for the visualisation of Xenon-129 nuclei. The company now supports Xenon MRI scanning from all three major scanner vendors, including GE Healthcare, Koninklijke Philips NV and Siemens Healthineers AG.

Chief Executive Officer Christopher von Jako says: "Expanding our FDA clearance to include GE HealthCare's platforms, following our previous clearance for Philips and Siemens systems, ensures that more institutions and clinicians across the US can access our innovative Xenon MRI technology. This expansion further enhances our ability to provide advanced imaging solutions to support patients and clinicians in the detection and ongoing monitoring of lung disease."

Current stock price: 1.55 pence, closed 1.6% higher in London on Thursday

12-month change: down 74%

By Emily Parsons, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Polarean Imaging PLC Ordinary Shares 1.55 GBX 1.64 -
Siemens AG 176.00 EUR -0.32

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures